细胞名称:4t1乳腺癌细胞 小鼠乳腺癌细胞
细胞简称:4T1
产品货号:TCM-C705
特征:乳腺癌
细胞形态:上皮细胞样
生长特性:贴壁生长培养体系:RPMI-1640+10%FBS+1%P/S
4t1乳腺癌细胞培养基货号:TCM-G705
4t1乳腺癌细胞
细胞名称:4t1乳腺癌细胞 小鼠乳腺癌细胞
细胞简称:4T1
产品货号:TCM-C705
种属来源:小鼠
组织来源:乳腺
特征:乳腺癌
细胞形态:上皮细胞样
生长特性:贴壁生长
培养体系:RPMI-1640+10%FBS+1%P/S
4t1乳腺癌细胞培养基货号:TCM-G705
传代比例:1:3-1:6,每2-3天换液一次
传代周期:48-72 h
培养条件:气相:95%空气+5%CO2,温度:37℃
冻存条件:60%基础培养基+30%FBS+10%DMSO,液氮储存
质量检测:细菌、真菌、支原体检测均为阴性
4T1是从410.4瘤株中未经诱变筛得的6-硫鸟嘌噙抗性细胞株。当注射到BALB/c小鼠中时,4T1自发产生高转移肿瘤,可转移到肺,肝,淋巴结和大脑,同时在注射部位形成始发灶。诱导转移时不需要摘除始发灶。4T1细胞在BALB/c小鼠中的生长与转移特性与人体中的乳腺癌十分相近。这种肿瘤是人VI期乳腺癌的动物模型。4T1-诱导的肿瘤在手术后及未手术情况下转移的动力学相近,可以用作手术后及未手术模型。跟其他肿瘤模型相比,由于4T1的抗6-硫鸟嘌噙特性,微小的转移细胞团(少到仅仅1个)也可以在许多远端器官中检测到。
参考文献:
Pulaski BA, et al. Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon gamma. Cancer Immunol. Immunother. 49: 34-45, 2000. PubMed: 10782864
Pulaski BA, Ostrand-Rosenberg S. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Cancer Res. 58: 1486-1493, 1998. PubMed: 9537252
Pulaski BA, et al. Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model. Cancer Res. 60: 2710-2715, 2000. PubMed: 10825145
Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 52: 1399-1405, 1992. PubMed: 1540948